Unknown. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Unknown. Condizione: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
Condizione: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Lingua: Inglese
ISBN 10: 1398854255 ISBN 13: 9781398854253
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condizione: Very Good. No Jacket. Missing dust jacket; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Lingua: Inglese
Editore: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Editore: Performance Programme Dated Saturday 18th March . 2000., 2000
Da: Little Stour Books PBFA Member, Canterbury, Regno Unito
Membro dell'associazione: PBFA
EUR 9,56
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Editore: Performance Programme Dated Saturday 2nd March . 2002., 2002
Da: Little Stour Books PBFA Member, Canterbury, Regno Unito
Membro dell'associazione: PBFA
EUR 9,56
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Editore: Performance Programme Dated Saturday 12th March . 1994., 1994
Da: Little Stour Books PBFA Member, Canterbury, Regno Unito
Membro dell'associazione: PBFA
EUR 9,56
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Fine. Original stapled illustrated souvenir programme. 8½'' x 5½''. Contains 20 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Editore: Performance Programme Dated Saturday 2nd March . 2002., 2002
Da: Little Stour Books PBFA Member, Canterbury, Regno Unito
Membro dell'associazione: PBFA
EUR 9,56
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].
Lingua: Inglese
Editore: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 119,95
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 119,94
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: Rarewaves USA, OSWEGO, IL, U.S.A.
EUR 152,33
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Lingua: Inglese
Editore: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 154,81
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Lingua: Inglese
Editore: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 141,06
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Emerald Publishing Limited, 2008
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 131,51
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. Like New. book.
Lingua: Inglese
Editore: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: Rarewaves USA United, OSWEGO, IL, U.S.A.
EUR 155,27
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Da: Revaluation Books, Exeter, Regno Unito
EUR 209,61
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 250 pages. 9.25x6.25x1.25 inches. In Stock.
Lingua: Inglese
Editore: Emerald Publishing Limited, US, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: Rarewaves.com UK, London, Regno Unito
EUR 146,02
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.
Lingua: Inglese
Editore: Emerald Group Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 124,44
Quantità: Più di 20 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Lingua: Inglese
Editore: Emerald Publishing Limited, 2007
ISBN 10: 0762313463 ISBN 13: 9780762313464
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 143,49
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Da: moluna, Greven, Germania
EUR 160,70
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. InhaltsverzeichnisContents: Introduction (I. Farquhar, K. Summers, A. Sorkin). INNOVATION IN REGULATORY AND OUTCOMES RESEARCH APPLICATIONS (1) After-Market Drug Regulation: Promoting Public Trust in Innovation (R. Field) (2) Transcendin.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. Print on Demand pp. 250.
Da: Majestic Books, Hounslow, Regno Unito
EUR 236,90
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 250.
Da: preigu, Osnabrück, Germania
EUR 166,60
Quantità: 5 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Value of Innovation | Irina Farquhar (u. a.) | Buch | Gebunden | Englisch | 2008 | Jai Press Inc. | EAN 9780762313464 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 233,28
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 250.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 199,10
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs.